<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Becton Dickinson And Company — News on 6ix</title>
<link>https://6ix.com/company/becton-dickinson-and-company</link>
<description>Latest news and press releases for Becton Dickinson And Company on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 10:50:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/becton-dickinson-and-company" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68354bed78dffbe2df0e54d2.webp</url>
<title>Becton Dickinson And Company</title>
<link>https://6ix.com/company/becton-dickinson-and-company</link>
</image>
<item>
<title>BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/bd-reimagines-central-line-insertion-advancing-leadership-in-patient-safety-through-breakthrough-vascular-access-technology</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/bd-reimagines-central-line-insertion-advancing-leadership-in-patient-safety-through-breakthrough-vascular-access-technology</guid>
<pubDate>Wed, 29 Apr 2026 10:50:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial launch of the BD® CentroVena One™ Insertion System, the first all-in-one central venous catheter (CVC) insertion device on the market. The system is designed to simplify central line placement for clinicians and enhance patient safety by streamlining key steps and incorporating safety-focused design elements that support consistent, efficient care in high-pressure acute set</description>
</item>
<item>
<title>BD Earns Industry Top Honors for Transparency, Resiliency and Partnership</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/bd-earns-industry-top-honors-for-transparency-resiliency-and-partnership</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/bd-earns-industry-top-honors-for-transparency-resiliency-and-partnership</guid>
<pubDate>Thu, 16 Apr 2026 10:50:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has been recognized by the Healthcare Industry Resilience Collaborative (HIRC) as the only supplier to receive HIRC's inaugural Member Choice Awards across three categories, Transparency, Resiliency and Partnership. Selected by HIRC members based on real–world customer experience, the awards acknowledge suppliers whose actions strengthen supply chain transparency, resilience, and continuity of patient ca</description>
</item>
<item>
<title>BD to Announce Financial Results for its Second Quarter of Fiscal 2026</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/bd-to-announce-financial-results-for-its-second-quarter-of-fiscal-2026</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/bd-to-announce-financial-results-for-its-second-quarter-of-fiscal-2026</guid>
<pubDate>Thu, 09 Apr 2026 20:15:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, May 7, 2026 to discuss the Company's financial results for its second quarter of fiscal year 2026, which ended on March 31, 2026, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors, and a replay will be made available sh</description>
</item>
<item>
<title>Rick Byrd to Retire from BD</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/rick-byrd-to-retire-from-bd</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/rick-byrd-to-retire-from-bd</guid>
<pubDate>Thu, 09 Apr 2026 20:05:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Richard (Rick) Byrd has informed the company of his intent to retire after nearly 25 years with BD.</description>
</item>
<item>
<title>For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/for-women-managing-nighttime-incontinence-better-sleep-and-comfort-start-with-bdr-purewickr-urine-collection-system</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/for-women-managing-nighttime-incontinence-better-sleep-and-comfort-start-with-bdr-purewickr-urine-collection-system</guid>
<pubDate>Thu, 09 Apr 2026 10:50:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new clinical findings revealing that women managing nighttime urinary incontinence reported better sleep and greater overall comfort when using the BD PureWick® Urine Collection System. According to the study, published in the Journal of Clinical Medicine, participants highlighted the system's ease of use and the non-invasive design of the PureWick® Flex Female External Catheter as key fa</description>
</item>
<item>
<title>BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/bd-delivers-nextgeneration-tips-innovation-to-advance-portal-hypertension-care-across-the-european-union</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/bd-delivers-nextgeneration-tips-innovation-to-advance-portal-hypertension-care-across-the-european-union</guid>
<pubDate>Wed, 08 Apr 2026 10:50:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced application of CE Mark for the Liverty™ TIPS Stent Graft, delivering innovation to portal hypertension care across the European Union. Designed to expand treatment options for patients with cirrhosis and complications of portal hypertension, our next‑generation, adjustable‑diameter device represents the latest advancement by BD in interventional therapies addressing complex liver disease.</description>
</item>
<item>
<title>When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/when-every-beat-matters-bd-helps-clinicians-eliminate-blind-spots-with-continuous-noninvasive-blood-pressure-insight</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/when-every-beat-matters-bd-helps-clinicians-eliminate-blind-spots-with-continuous-noninvasive-blood-pressure-insight</guid>
<pubDate>Tue, 07 Apr 2026 10:50:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the HemoSphere Stream™ Module, a new innovation which gives clinicians continuous, noninvasive visibility into patients' blood pressure. The module delivers real-time, beat-to-beat arterial waveform data from a noninvasive finger cuff directly to compatible multiparameter patient monitors, helping clinicians close gaps between intermittent readings.</description>
</item>
<item>
<title>BD Launches AI-Enabled Medication Dispensing System to the European Market</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/bd-launches-ai-enabled-medication-dispensing-system-to-the-european-market</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/bd-launches-ai-enabled-medication-dispensing-system-to-the-european-market</guid>
<pubDate>Wed, 01 Apr 2026 09:00:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD® Pyxis™ Pro Dispensing Solution and BD® Incada™ Connected Care Platform in Europe. This next-generation medication dispensing system combines advanced automation and AI‑driven insights to modernize medication management, reduce disruptions, and improve efficiency while helping clinicians spend more time on patient care.</description>
</item>
<item>
<title>BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/bd-pioneers-new-standard-in-surgical-safety-with-fda-cleared-surgiphortm-1000ml-for-wound-irrigation</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/bd-pioneers-new-standard-in-surgical-safety-with-fda-cleared-surgiphortm-1000ml-for-wound-irrigation</guid>
<pubDate>Mon, 02 Mar 2026 11:50:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Surgiphor™ 1000mL. As the first and only 1000 mL antimicrobial irrigation system specifically designed for powered lavage, Surgiphor™ 1000mL provides a standardized, OR-ready solution that enhances surgical safety and efficacy.</description>
</item>
<item>
<title>Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/becton-dickinson-and-company-announces-pricing-of-the-tender-offers-and-amounts-accepted-for-purchase</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/becton-dickinson-and-company-announces-pricing-of-the-tender-offers-and-amounts-accepted-for-purchase</guid>
<pubDate>Wed, 25 Feb 2026 21:15:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology company, today announced the consideration payable in connection with its previously announced Tender Offers (as defined below) to purchase for cash up to $2,000,000,000 aggregate purchase price, excluding the applicable Accrued Interest (as defined below) (which, subject to applicable law, may be increased or decreased in the Company's sole discretion, the "Aggregate Offer Cap") of its (i</description>
</item>
<item>
<title>Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/becton-dickinson-and-company-announces-early-tender-results-and-upsizing-of-offer-subcap-and-aggregate-offer-cap</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/becton-dickinson-and-company-announces-early-tender-results-and-upsizing-of-offer-subcap-and-aggregate-offer-cap</guid>
<pubDate>Wed, 25 Feb 2026 13:00:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology company, today announced the early tender results for its previously announced Tender Offers (as defined below) to purchase for cash certain of its outstanding debt securities listed in the table below.</description>
</item>
<item>
<title>BD to Present at Barclays 28th Annual Global Healthcare Conference</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/bd-to-present-at-barclays-28th-annual-global-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/bd-to-present-at-barclays-28th-annual-global-healthcare-conference</guid>
<pubDate>Mon, 23 Feb 2026 21:15:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 8:30 am Eastern Time.</description>
</item>
<item>
<title>BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/bd-expands-testing-capabilities-to-help-clinicians-improve-diagnostic-accuracy-and-efficiency</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/bd-expands-testing-capabilities-to-help-clinicians-improve-diagnostic-accuracy-and-efficiency</guid>
<pubDate>Mon, 23 Feb 2026 11:50:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD Vacutainer® Urine Complete Cup Kit, a three-tube collection system that expands and supports broader testing capabilities from a single urine specimen.</description>
</item>
<item>
<title>Lanesha Minnix Named General Counsel for BD</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/lanesha-minnix-named-general-counsel-for-bd</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/lanesha-minnix-named-general-counsel-for-bd</guid>
<pubDate>Thu, 19 Feb 2026 21:15:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Lanesha Minnix has been named executive vice president and general counsel for the company, effective March 16.</description>
</item>
<item>
<title>Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/becton-dickinson-and-company-announces-tender-offers-for-outstanding-debt-securities</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/becton-dickinson-and-company-announces-tender-offers-for-outstanding-debt-securities</guid>
<pubDate>Tue, 10 Feb 2026 18:00:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology company, today announced that it has commenced tender offers to purchase for cash the debt securities issued by the Company listed in the table below (collectively, the "Securities" and each a "series").</description>
</item>
<item>
<title>BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/bd-completes-combination-biosciences-diagnostic-134000014</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/bd-completes-combination-biosciences-diagnostic-134000014</guid>
<pubDate>Mon, 09 Feb 2026 13:40:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the successful completion of the previously announced spin-off of BD's Biosciences & Diagnostic Solutions business and the combination of the business with Waters Corporation (NYSE: WAT).</description>
</item>
<item>
<title>Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/waters-completes-combination-with-bds-biosciences-and-diagnostic-solutions-businesses</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/waters-completes-combination-with-bds-biosciences-and-diagnostic-solutions-businesses</guid>
<pubDate>Mon, 09 Feb 2026 13:40:00 GMT</pubDate>
<description>Waters Corporation (NYSE: WAT) ("Waters") today announced it has completed the previously announced combination with the Biosciences & Diagnostic Solutions businesses of Becton, Dickinson and Company (NYSE: BDX) ("BD"). The transaction forms a global life sciences and diagnostics leader, equipped with best-in-class technologies, and an industry-leading financial outlook. The Company also announced the appointment of Claire M. Fraser, Ph.D., to its Board of Directors (the "Waters Board"), increas</description>
</item>
<item>
<title>BD Reports First Quarter Fiscal 2026 Financial Results</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/bd-reports-first-quarter-fiscal-113000697</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/bd-reports-first-quarter-fiscal-113000697</guid>
<pubDate>Mon, 09 Feb 2026 11:30:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2026 first quarter, which ended December 31, 2025.</description>
</item>
<item>
<title>BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/bd-envetec-demonstrate-closed-loop-115000194</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/bd-envetec-demonstrate-closed-loop-115000194</guid>
<pubDate>Thu, 29 Jan 2026 11:50:00 GMT</pubDate>
<description>BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Envetec Sustainable Technologies ("Envetec"), announced today the successful completion of a joint feasibility study to test the ability to recycle polystyrene Petri dishes into new, high-quality manufacturing feedstock.</description>
</item>
<item>
<title>BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26</title>
<link>https://6ix.com/company/becton-dickinson-and-company/news/bd-board-declares-dividend-authorizes-211500154</link>
<guid isPermaLink="true">https://6ix.com/company/becton-dickinson-and-company/news/bd-board-declares-dividend-authorizes-211500154</guid>
<pubDate>Tue, 27 Jan 2026 21:15:00 GMT</pubDate>
<description>The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.05 per common share, payable on March 31, 2026, to holders of record on March 10, 2026. The indicated annual dividend rate is $4.20 per share.</description>
</item>
</channel>
</rss>